Relay Therapeutics and EcoR1 Capital News

This is selected news for Relay Therapeutics and EcoR1 Capital, which are filed under Sectors / Healthtech and Capital Firms, respectively. There are 12 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/25/2021 Swiss National Bank Acquires 8,000 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
Swiss National Bank lifted its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) by 13.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 69,700 shares of the company's stock after purchasing an additional 8,000 ...
American Banking News
9/9/2021 Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by American Century Companies Inc. - Transcript Daily
... most recent SEC filing. A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. EcoR1 Capital LLC increased its holdings in shares of Relay Therapeutics by 7.1% in the first quarter. EcoR1 Capital LLC now owns 3,429,363 shares of ...
transcriptdaily.com
8/27/2021 Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Acquired by Royal Bank of Canada - The Cerbat Gem
Royal Bank of Canada increased its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) by 1,609.9% during the 1st quarter, Holdings Channel.com reports. The fund owned 5,865 shares of the company's stock after acquiring an additional 5,522 shares during the period. Royal Bank of Canada's holdings in ...
thecerbatgem.com
8/21/2021 Millennium Management LLC Trims Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)
... the first quarter. BlackRock Inc. now owns 3,798,730 shares of the company's stock worth $131,322,000 after buying an additional 641,756 shares during the period. EcoR1 Capital LLC grew its stake in Relay Therapeutics by 7.1% in the first quarter. EcoR1 Capital LLC now owns 3,429,363 shares of the company ...
dispatchtribunal.com
8/16/2021 Alliancebernstein L.P. Purchases 191,474 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
Alliancebernstein L.P. increased its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) by 18.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,244,765 shares of the company's stock after buying an additional 191,474 shares ...
baseballnewssource.com
7/14/2021 Rock Springs Capital Management LP Sells 159,873 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
... Rowe Associates Inc. MD now owns 1,505,092 shares of the company's stock worth $52,031,000 after buying an additional 731,517 shares during the last quarter. EcoR1 Capital LLC boosted its holdings in Relay Therapeutics by 7.1% in the first quarter. EcoR1 Capital LLC now owns 3,429,363 shares of the company ...
Mayfield Recorder
3/30/2021 Tudor Investment Corp Et Al Purchases 23,939 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY)
Tudor Investment Corp Et Al Purchases 23,939 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) Posted by Jared Coughlin on Mar 30th, 2021 Tudor Investment Corp Et Al raised its position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) by 123.7% in the fourth quarter, according to the company in its ...
com-unik.info
3/27/2021 Relay Therapeutics, Inc. (NASDAQ:RLAY) Stake Raised by Citigroup Inc.
... their holdings of RLAY. SB Investment Advisers UK Ltd. purchased a new stake in shares of Relay Therapeutics in the third quarter worth approximately $1,188,472,000. EcoR1 Capital LLC purchased a new stake in Relay Therapeutics in the 3rd quarter worth approximately $136,316,000. BlackRock Inc. lifted its position in Relay Therapeutics ...
thelincolnianonline.com
3/26/2021 HighVista Strategies LLC Acquires Shares of 14,975 Relay Therapeutics, Inc. (NASDAQ:RLAY)
HighVista Strategies LLC Acquires Shares of 14,975 Relay Therapeutics, Inc. (NASDAQ:RLAY) Posted by John Perry HighVista Strategies LLC acquired a new position in shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired ...
zolmax.com
1/6/2020 Relay Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
... company launched in 2016. To date the company has raised $520M from investors including SoftBank Vision Fund, Third Rock Ventures, Casdin Capital, GV, BVF Partners, EcoR1 Capital, Foresite Capital, Perceptive Advisors, Tavistock Group and an affiliate of D.E. Shaw Research. Contacts Katie Engleman 1AB [email protected] ...
Business Wire
11/19/2019 Relay Therapeutics Strengthens Leadership Team with Key Team Appointments in Research and Development | Business & Finance | manchestertimes.com
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 19, 2019-- Relay Therapeutics , a new breed of company at the intersection of computation and biotechnology, today announced that Ben B. Wolf, M.D., Ph.D., has joined as chief medical officer, Mrunal “Monica” Phadnis has joined as vice president of clinical operations and Iain Martin, Ph.D ...
Business Wire
11/5/2019 Relay Therapeutics Appoints Human Resources Expert Andy Porter as Executive Vice President and Chief People Officer | Business & Finance | heraldchronicle.com
... company launched in 2016. To date the company has raised $520M from investors including SoftBank Vision Fund, Third Rock Ventures, Casdin Capital, GV, BVF Partners, EcoR1 Capital, Foresite Capital, Perceptive Advisors, Tavistock Group and an affiliate of D.E. Shaw Research. View source version on businesswire.com : https://www.businesswire.com/news/home/20191105005016 ...
Business Wire